The necessity for personalization extends to sales and marketing operations too as pharma corporations are increasingly needing to compete for the eye of health-care professionals (HCPs). Estimates suggest that biopharmas were in a position to reach 45% of HCPs in 2024, down from 60% in 2022. Personalization, real-time communication channels, and relevant content offer a way of constructing trust and reaching HCPs in an increasingly competitive market. But with ever-growing volumes of content requiring medical, legal, and regulatory (MLR) review, corporations are struggling to maintain up, resulting in potential delays and missed opportunities.
What are your thoughts on this topic?
Let us know in the comments below.
0 Comments
Oldest
